Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of YHP1701 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of YHP1701 for hypertension and hyperlipidemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• YHP1701

Snippet

Sponsor: Yuhan Corporation | Conditions: Hypertension and Hyperlipidemia | Phase 3 | Status: COMPLETED